Dextran
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09255 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hemoglobinopathy | KG + DL |
| 2 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 3 | beta-thalassemia with other manifestations | KG + DL |
| 4 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 5 | rheumatoid arthritis | KG + DL |
| 6 | pyruvate kinase deficiency of red cells | KG + DL |
| 7 | pyropoikilocytosis, hereditary | KG + DL |
| 8 | female breast carcinoma | KG + DL |
| 9 | thrombotic disease | KG + DL |
| 10 | peripheral vascular disease | KG + DL |
| 11 | myocardial infarction | KG + DL |
| 12 | peripheral arterial disease | KG + DL |
| 13 | myocardial infarction (disease) | KG + DL |
| 14 | Prinzmetal angina | KG + DL |
| 15 | coronary thrombosis | KG + DL |
| 16 | antithrombin deficiency type 2 | KG + DL |
| 17 | angiodysplasia | KG + DL |
| 18 | venous thromboembolism | KG + DL |
| 19 | fibrocartilaginous embolism | KG + DL |
| 20 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 21 | non-inflammatory vasculopathy | KG + DL |
| 22 | heparin cofactor 2 deficiency | KG + DL |
| 23 | vascular ectasia | KG + DL |
| 24 | ischemic disease | KG + DL |
| 25 | congenital renal artery stenosis | KG + DL |
| 26 | epiglottitis | KG + DL |
| 27 | thrombophilia | KG + DL |
| 28 | coronary stenosis | KG + DL |
| 29 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 30 | vein disease | KG + DL |
| 31 | intermittent vascular claudication | KG + DL |
| 32 | septal myocardial infarction | KG + DL |
| 33 | posterolateral myocardial infarction | KG + DL |
| 34 | posteroinferior myocardial infarction | KG + DL |
| 35 | brachydactyly-syndactyly syndrome | KG + DL |
| 36 | osteoarthritis susceptibility | KG + DL |
| 37 | laryngitis | KG + DL |
| 38 | breast fibrocystic disease | KG + DL |
| 39 | congenital coronary artery anomaly | KG + DL |
| 40 | intracranial arteriosclerosis | KG + DL |
| 41 | gout | KG + DL |
| 42 | vascular insufficiency disorder | KG + DL |
| 43 | headache disorder | KG + DL |
| 44 | hereditary arterial and articular multiple calcification syndrome | KG + DL |
| 45 | trigeminal autonomic cephalalgia | KG + DL |
| 46 | Monckeberg arteriosclerosis | KG + DL |
| 47 | infectious otitis media | KG + DL |
| 48 | blunt duct adenosis of breast | KG + DL |
| 49 | apocrine adenosis of breast | KG + DL |
| 50 | endocarditis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.